➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
McKesson
Moodys
Harvard Business School
Johnson and Johnson

Last Updated: June 1, 2020

DrugPatentWatch Database Preview

Patent: 7,674,810

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,674,810
Title:1,1-dioxo-1H-1.LAMBDA..sup.6-benzo[d]isothiazol-3-yl)-4-hydroxy-1,5-dihydr- o-pyrrol-2-one inhibitors of HCV polymerase
Abstract: Compounds having the formula i wherein m, R.sup.1, R.sup.2, R.sup.4 and X.sup.1 are herein defined are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for inhibiting hepatitis replication, processes for making the compounds and synthetic intermediates used in the process. ##STR00001##
Inventor(s): Blake; James F. (Longmont, CO), Fell; Jay Bradford (Longmont, CO), Fischer; John P. (Longmont, CO), Hendricks; Robert Than (San Carlos, CA), Spencer; Stacey Renee (Lyons, CO), Stengel; Peter J. (Longmont, CO)
Assignee: Roche Palo Alto LLC (Palo Alto, CA)
Application Number:11/413,872
Patent Claims:see list of patent claims

Details for Patent 7,674,810

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 001 2001-01-19   Start Trial Roche Palo Alto LLC (Palo Alto, CA) 2039-02-26 RX search
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 002 2001-01-19   Start Trial Roche Palo Alto LLC (Palo Alto, CA) 2039-02-26 RX search
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 003 2001-01-19   Start Trial Roche Palo Alto LLC (Palo Alto, CA) 2039-02-26 RX search
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 004 2001-01-19   Start Trial Roche Palo Alto LLC (Palo Alto, CA) 2039-02-26 RX search
Schering PEGINTRON peginterferon alfa-2b SYRINGE 103949 005 2001-01-19   Start Trial Roche Palo Alto LLC (Palo Alto, CA) 2039-02-26 RX search
Schering PEGINTRON peginterferon alfa-2b SYRINGE 103949 006 2001-01-19   Start Trial Roche Palo Alto LLC (Palo Alto, CA) 2039-02-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
McKinsey
Medtronic
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.